Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough.
Present work conceptualizes a specific technology, based on combining floating and pulsatile principles to develop drug delivery system, intended for chronotherapy in nocturnal acid breakthrough. This approach will be achieved by using a programmed delivery of ranitidine hydrochloride from a floating tablet with time-lagged coating. In this study, investigation of the functionality of the outer polymer coating to predict lag time and drug release was statistically analyzed using the response surface methodology (RSM). RSM was employed for designing of the experiment, generation of mathematical models and optimization study. The chosen independent variables, i.e. percentage weight ratios of ethyl cellulose to hydroxypropyl methyl cellulose in the coating formulation and coating level (% weight gain) were optimized with a 3(2) full factorial design. Lag time prior to drug release and cumulative percentage drug release in 7h were selected as responses. Results revealed that both, the coating composition and coating level, are significant factors affecting drug release profile. A second-order polynomial equation fitted to the data was used to predict the responses in the optimal region. The optimized formulation prepared according to computer-determined levels provided a release profile, which was close to the predicted values. The proposed mathematical model is found to be robust and accurate for optimization of time-lagged coating formulations for programmable pulsatile release of ranitidine hydrochloride, consistent with the demands of nocturnal acid breakthrough.
Roy
Pallab
P
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research - Ahmedabad, C/o B.V. Patel Pharmaceutical Education and Research Development (PERD) Centre, Sarkhej-Gandhinagar Highway, Thaltej, Gujarat, India.
Shahiwala
Aliasgar
A
D002482:Cellulose / Q000031:analogs & derivatives; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems; D005079:Excipients; D005744:Gastric Acid / Q000737:chemistry; D006635:Histamine H2 Antagonists / Q000008:administration & dosage* / Q000737:chemistry*; D065347:Hypromellose Derivatives; D007700:Kinetics; D008747:Methylcellulose / Q000031:analogs & derivatives; D015233:Models, Statistical; D011899:Ranitidine / Q000008:administration & dosage* / Q000737:chemistry*; D012044:Regression Analysis; D012995:Solubility; D013608:Tablets, Enteric-Coated
D003692:Delayed-Action Preparations; D005079:Excipients; D006635:Histamine H2 Antagonists; D013608:Tablets, Enteric-Coated; D065347:Hypromellose Derivatives; C013517:ethyl cellulose; D011899:Ranitidine; D002482:Cellulose; D008747:Methylcellulose